- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/675 - Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
Patent holdings for IPC class A61K 31/675
Total number of patents in this class: 4225
10-year publication summary
|
317
|
341
|
361
|
377
|
371
|
369
|
487
|
489
|
420
|
119
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Gilead Sciences, Inc. | 1879 |
112 |
| Antecip Bioventures II LLC | 300 |
101 |
| Iovance Biotherapeutics, Inc. | 301 |
59 |
| Merck Sharp & Dohme LLC | 3689 |
46 |
| The Regents of the University of California | 18943 |
40 |
| Bristol-myers Squibb Company | 5080 |
36 |
| Immunomedics, Inc. | 290 |
36 |
| Novartis AG | 11238 |
35 |
| Rigel Pharmaceuticals, Inc. | 613 |
35 |
| The Johns Hopkins University | 5377 |
34 |
| Psilo Scientific Ltd. | 50 |
32 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
28 |
| Achillion Pharmaceuticals, Inc. | 176 |
23 |
| Cipla Limited | 469 |
23 |
| Centre National de La Recherche Scientifique | 9632 |
21 |
| Takeda Pharmaceutical Company Limited | 2961 |
21 |
| Allergan, Inc. | 2600 |
19 |
| Pharmacyclics LLC | 240 |
18 |
| University of South Florida | 1817 |
16 |
| Regents of the University of Minnesota | 2620 |
16 |
| Other owners | 3474 |